You can find all information about SARS-CoV-2 vaccinations for children here.
Children from 6 years of age in risk areas—i.e., in almost all areas of Switzerland. Recommended from the age of 3, especially for children who frequently spend time in forests and meadows, such as those in forest kindergartens. Vaccination is also recommended for adults, especially from the age of 50.
We will advise you on the vaccination and answer all your questions. Then your child will be briefly examined to rule out any illness.
We administer vaccinations with your child comfortably seated on your lap or in your arms. More confident children may choose to sit independently. The skin area, usually the upper arm, is briefly disinfected. This is followed by a small prick, then a plaster on the injection site.
At the end, your child will, of course, be allowed to choose something from our treasure chest.
Your child will be well protected against TBE from as early as their second vaccination. This is usually administered after 4 weeks. You can also opt for an accelerated schedule, with the second vaccination being administered after just two weeks. A third booster vaccination is then administered after 5–12 months.
The TBE vaccination is usually very well tolerated. Occasionally, your child's arm may hurt for 1–2 days after the vaccination, as if the muscle was sore. The area can also turn red or develop a small bruise. Other side effects, such as headache, fever, muscle pain, restlessness or dizziness, are rare.
You are welcome to book an appointment by phone directly at our locations or via our contact form. In urgent cases, you can usually visit without an appointment.
For patients in risk areas, the costs for the vaccination are covered by compulsory health insurance.
Vaccination against influenza is recommended for individuals who suffer from increased risk of complications from the flu:
For whom is the vaccine not recommended?
The probability of experiencing serious adverse reactions after vaccination is massively smaller than the risk of serious complications from flu.
For individuals who are at an increased risk of complications from the flu, the cost of vaccination is covered by compulsory health insurance, as long as the deductible has already been reached.
Source: Federal Office of Public Health
Since 2024, a medication for immunization against RSV has been approved in Switzerland; this can prevent severe RSV infections. This is an antibody treatment that functions like a vaccination and is administered as a single injection at the start of the winter months. As they are antibodies, protection is immediate after administration. The body does not have to produce antibodies first, as is the case with a vaccination.
We recommend this immunization treatment for all infants born in April of the same year they experience their first winter. For children with heart defects, lung diseases, and similar conditions, the treatment is also recommended during their second winter.
The treatment is administered starting in October and provides protection against severe RSV infection for the entire remaining winter. In other countries, this has reduced the risk of serious RSV infections by 80%.
The costs are covered by health insurance.